2μg (R: reducing condition, N:non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Cynomolgus |
| Synonyms | TSLP |
| Accession | A0A7N9CAT7 |
| Amino Acid Sequence | Tyr29-Gln159 with His Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 8-10 kDa&15-20 kDa (Reducing) |
| Purity | >95% by SDS-PAGE,>90% by HPLC |
| Conjugation | Unconjugated |
| Tag | His Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, pH7.4, 5% trehalose |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | 1.Cheng DT, Ma C, Niewoehner J, Dahl M, Tsai A, Zhang J, Gonsiorek W, Apparsundaram S, Pashine A, Ravindran P, Jung J, Hang J, Allard J, Bitter H, Tribouley C, Narula S, Wilson S, Fuentes ME. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol. 2013 Aug;132(2):455-62. |
Background
TSLP (thymic stromal lymphopoietin) is an IL-7-like cytokine produced by epithelial cells that activates the JAK/STAT signaling pathway through a ternary complex composed of its receptor TSLPR and IL-7Rα, driving dendritic cell maturation and Th2-type immune responses, and serving as a core upstream regulator of type 2 inflammation (asthma, atopic dermatitis). Due to >95% sequence homology of TSLP between cynomolgus monkeys and humans, cynomolgus monkeys have become a critical species for nonclinical safety evaluation of anti-TSLP therapeutics such as tezepelumab; their asthma models have effectively validated the in vivo efficacy of TSLP/TSLPR blockade strategies, providing irreplaceable translational medicine evidence for the development of TSLP-targeting antibody drugs.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of TSLP His Tag Protein, Cynomolgus is more than 90% determined by SEC-HPLC.
ELISA
Immobilized TSLP His Tag Protein, Cynomolgus (Cat. No.UA016147) at 1.0μg/mL (100μL/well) can bind TSLPR Fc Chimera Protein, Human(Cat. No.UA010907) with EC50 of 0.72-2.84ng/mL.
Immobilized TSLP His Tag Protein, Cynomolgus (Cat. No.UA016147) at 1.0μg/mL (100μL/well) can bind Anti-TSLP Monoclonal Antibody (Tezepelumab)(Cat. No.S0B7094) with EC50 of 1.29-4.69ng/mL.
